PSC
EGRX

Piper Sandler & Co’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Piper Sandler & Co’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q3 		$7K Buy
+100
New +$7K 0.01% 11
2014
Q3 		– Sell
-1,277
Closed -$18K – 170
2014
Q2 		$18K Buy
+1,277
New +$18K 0.01% 108